[Current "off label use" of methotrexate for chronic inflammatory rheumatic diseases].
Methotrexate (MTX) is probably the most commonly used off-label drug in rheumatology. It is used as an immunosuppressant for a wide range of chronic inflammatory rheumatic diseases. In most cases there is limited evidence from controlled studies for the efficacy of MTX in this off-label scenario. Only a few controlled clinical trials exist for different types of connective tissue diseases and vasculitis. In most indications, however, MTX could help to avoid using steroids and/or to prevent relapses. Thus, there is a great deal of experience with MTX in an off-label use and MTX is employed in the daily practice by most rheumatologists with success. A commonly used register indexing the off-label use of MTX and also of other disease-modifying antirheumatic drugs (DMARDs) and biologicals would help to improve the acceptance and the safety of MTX as an orphan drug.
Sektion Rheumatologie , Medizinische Klinik V, Universitätsklinik Heidelberg, Im Neuenheimer Feld 410, Heidelberg, Germany. steffen.briem@freenet.de
S
S
Briem
H-M
HM
Lorenz
D018501:Antirheumatic Agents / Q000627:therapeutic use*; D002908:Chronic Disease; D005858:Germany; D006801:Humans; D007249:Inflammation / Q000188:drug therapy*; D008727:Methotrexate / Q000627:therapeutic use*; D056687:Off-Label Use; D012216:Rheumatic Diseases / Q000188:drug therapy*
D018501:Antirheumatic Agents; D008727:Methotrexate
Eur Neurol. 1977;16(1-6):149-54
615706
J Am Acad Dermatol. 1995 May;32(5 Pt 1):754-7
7722021
Rheumatology (Oxford). 2004 Mar;43(3):315-20
14963200
J Neurol Sci. 1998 Aug 14;159(2):181-5
9741405
Lancet. 1971 Jan 2;1(7688):14-6
4099314
Arch Intern Med. 2009 Nov 9;169(20):1839-50
19901135
Clin Exp Rheumatol. 1996 Sep-Oct;14(5):555-8
8913659
Arthritis Rheum. 2001 Jun;44(6):1351-8
11407694
Clin Exp Rheumatol. 2010 Jan-Feb;28(1 Suppl 57):67-71
20412706
J Rheumatol. 1999 Jun;26(6):1275-9
10381042
Ann Intern Med. 2001 Jan 16;134(2):106-14
11177313
Rheumatology (Oxford). 2007 Jul;46(7):1047-8
17409129
Int J Dermatol. 2007 Feb;46(2):218-23
17269983
Arthritis Rheum. 2010 Apr;62(4):960-8
20131246
Rheumatology (Oxford). 2010 Jun;49(6):1164-72
20299380
Arthritis Rheum. 2008 Dec 15;59(12):1796-804
19035431
Rheumatology (Oxford). 2010 Feb;49(2):295-307
19946022
Dermatol Clin. 2010 Jul;28(3):489-99
20510759
Cochrane Database Syst Rev. 2006 Oct 18;(4):CD004524
17054209
Br J Dermatol. 2005 Jul;153(1):157-62
16029342
Br J Rheumatol. 1996 Apr;35(4):364-72
8624641
Arthritis Rheum. 2002 May;46(5):1309-18
12115238
Br J Dermatol. 2009 May;160(5):1075-82
19210503
Arthritis Rheum. 2007 Aug;56(8):2789-97
17665429
J Rheumatol. 2004 Aug;31(8):1568-74
15290737
Expert Opin Investig Drugs. 2000 Sep;9(9):2007-16
11060789
J Pediatr. 2007 Jan;150(1):72-6
17188618
Clin Exp Rheumatol. 2004;22(6 Suppl 36):S52-61
15675136
Arch Dermatol. 2005 Jul;141(7):847-52
16027298
Clin Exp Rheumatol. 2008 May-Jun;26(3):395-400
18578959
Lupus. 2001;10(3):162-4
11315346
Ann Rheum Dis. 2008 Jan;67(1):74-9
17545189
Rheumatology (Oxford). 2007 Jul;46(7):1087-91
17519271
Scand J Rheumatol. 2000;29(2):95-102
10777122
Ann Intern Med. 2004 Oct 5;141(7):493-500
15466766
Am J Clin Dermatol. 2009;10(6):365-81
19824738
Lupus. 2005;14(2):101-5
15751813